Skip to content

A Randomised Controlled Trial to Evaluate the Efficacy of Multiple End-points of the Abaltion Procedure in Paroxysmal Atrial Fibrillation Ablation

A Randomised Controlled Trial to Evaluate the Efficacy of Multiple End-points of the Abaltion Procedure in Paroxysmal Atrial Fibrillation Ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000567
Enrollment
Unknown
Registered
2009-10-28
Start date
2009-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal atrial fibrillation

Interventions

Group A:Circumstantial pulmonary vein isolation(CPVI)
Group B:CPVI + re-isolation guided by ATP-induction postisolation
Group C:CPVI + re-isolation guided by 30min of waiting period postisolation
Group D:CPVI + re-isolation guided by 30min of waiting period and ATP-induction postisolation

Sponsors

SIR RUN RUN SHAW Hospital of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Symptomatic paroxysmal AF; 2. Drug refractory; 3. Aged 18-75 yrs; 4. Able and willing to provide signed informed consent (at least 3 months).

Exclusion criteria

Exclusion criteria: 1. Reversible causes of atrial fibrillation; 2. Postoperative atrial fibrillation; 3. Previous left atrial ablation; 4. A documented intraatrial thrombus, tumor, or other abnormality that precludes catheter placement; 5. A contraindication to antiarrhythmic medicine, anticoagulation, adenosine or isoproterenol, Severe pulmonary disease; 6. Cardiac surgery, myocardial infarction, or percutaneous coronary intervention within the previous 3 months; 7. A life expectancy of 2 years or less; 8. A high probability of undergoing cardiac transplantation within the next 12 months.

Design outcomes

Primary

MeasureTime frame
Time of freedom form atrial fibrillation post-CPVI;

Secondary

MeasureTime frame
Left atrium size;Left ventricular ejection fraction;Left ventricular diastolic diameter;

Countries

China

Contacts

Public ContactChenyang Jiang
jiangchenyang@hotmail.com+86 13857190051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026